All In MedTech

FDA Clearance Tracker · P190016-S008

Tula System

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Dec 22, 2023 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Dec 22, 2023

Approved

Time to decision

175 days

Received Jun 30, 2023. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track No User Fee

Device class

Class III

The decision

FDA number
P190016-S008
Device name
Tula System
Applicant location
Menlo Park, CA
Received
Jun 30, 2023
Decided
Dec 22, 2023
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P190016

Device type

Device class
Class III

Every decision under product code QJA

FDA's approval statement

As written in FDA's record.

Approval for the sterilization of the Gen 2 Tube Delivery System (TDS) at the new contract sterilizer, Sterigenics, located in Costa Rica

Source documents

Other decisions for Tusker Medical, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.